Volume 15, Number 5—May 2009
Research
Cross-Border Dissemination of Methicillin-Resistant Staphylococcus aureus, Euregio Meuse-Rhin Region
Ruud H. Deurenberg
, Eric Nulens, Havard Valvatne, Silvie Sebastian, Christel Driessen, Jos Craeghs, Els De Brauwer, Bernhard Heising, Yvette J. Kraat, Joachim Riebe, Frans S. Stals, Thera A. Trienekens, Jacques Scheres, Alexander W. Friedrich, Frank H. Van Tiel, Patrick S. Beisser, and Ellen E. Stobberingh
, Eric Nulens, Havard Valvatne, Silvie Sebastian, Christel Driessen, Jos Craeghs, Els De Brauwer, Bernhard Heising, Yvette J. Kraat, Joachim Riebe, Frans S. Stals, Thera A. Trienekens, Jacques Scheres, Alexander W. Friedrich, Frank H. Van Tiel, Patrick S. Beisser, and Ellen E. StobberinghTable 1
Non–β-lactam antimicrobial drug resistance patterns of 257 MRSA isolates in the Euregio Meuse-Rhin region, July 2005–April 2006*
| Country | No. isolates | No. (%) resistant MRSA isolates |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CIP | MXF | CLI | GEN | CLR | SXT | TET | RIF | MUP | FUC | ||
| Belgium | 44 | 44 (100) | 43 (98) | 5 (11) | 2 (5) | 24 (55) | 0 | 4 (9) | 0 | 4 (9) | 0 |
| Germany | 92 | 89 (97) | 89 (97) | 78 (85) | 5 (5) | 83 (90) | 0 | 3 (3) | 2 (2) | 1 (1) | 1 (1) |
| The Netherlands | 121 | 84 (69) | 79 (65) | 76 (63) | 11 (9) | 93 (77) | 3 (2) | 22 (18) | 0 | 8 (7) | 1 (1) |
| Total | 257 | 217 (84) | 211 (82) | 159 (62) | 18 (7) | 200 (78) | 3 (1) | 29 (12) | 2 (1) | 13 (5) | 2 (1) |
*MRSA, methicillin-resistant Staphylococcus aureus; CIP, ciprofloxacin; MXF, moxifloxacin; CLI, clindamycin; GEN, gentamicin; CLR, clarithromycin; SXT, trimethoprim/sulfamethoxazole; TET, tetracycline; RIF, rifampin; MUP, mupirocin; FUC, fucidic acid. No isolates showed resistance to linezolid, vancomycin, or teicoplanin.
